42 participants
Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2014-08-25
- Start Date:
- 2010-07-31
- Completion:
- 2014-12-31
Conditions
- Non-Hodgkin Lymphoma
Interventions
- DRUG
No Results Yet